BlackRock Municipal Income Investment Quality Trust (BAF), Nuveen Enhanced Municipal Value Fund (NEV), Northrim BanCorp (NRIM) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 BlackRock Municipal Income Investment Quality Trust (BAF) 14.10 -0.49% 5.23% 2021-06-28 15:41:18
2 Nuveen Enhanced Municipal Value Fund (NEV) 17.42 2.35% 4.39% 2021-06-29 12:51:18
3 Northrim BanCorp (NRIM) 42.75 -0.56% 3.48% 2021-07-01 05:46:05
4 ENI S.p.A. (E) 24.67 -0.52% 3.44% 2021-07-02 15:37:11
5 Bristol (BMY) 66.95 0.59% 2.93% 2021-07-02 16:13:06
6 Camden National Corporation (CAC) 47.76 -0.04% 2.93% 2021-06-30 08:44:05

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. BlackRock Municipal Income Investment Quality Trust (BAF) – Dividend Yield: 5.23%

BlackRock Municipal Income Investment Quality Trust is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets of United States. It primarily invests in municipal bonds exempt from federal income taxes, including the alternative minimum tax and also in municipal bonds that are investment grade quality at the time of investment. The fund was formerly known as BlackRock Insured Municipal Income Investment Trust. BlackRock Municipal Income Investment Quality Trust was formed on October 31, 2002 and is domiciled in United States.

Volume

Today’s last reported volume for BlackRock Municipal Income Investment Quality Trust is 77361, 313.34% above its average volume of 18716.

BlackRock Municipal Income Investment Quality Trust’s last close was $14.10, 13.87% below its 52-week high of $16.37.

BlackRock Municipal Income Investment Quality Trust’s Revenue

Year-on-year quarterly revenue growth declined by 4.2%, now sitting on 8.99M for the twelve trailing months.

BlackRock Municipal Income Investment Quality Trust’s Stock Yearly Top and Bottom Value

BlackRock Municipal Income Investment Quality Trust’s stock is valued at $14.10 at 05:15 EST, way under its 52-week high of $16.37 and way above its 52-week low of $12.35.

BlackRock Municipal Income Investment Quality Trust’s Moving Average

BlackRock Municipal Income Investment Quality Trust’s worth is under its 50-day moving average of $14.72 and under its 200-day moving average of $14.70.

More news about BlackRock Municipal Income Investment Quality Trust.

2. Nuveen Enhanced Municipal Value Fund (NEV) – Dividend Yield: 4.39%

Nuveen Enhanced Municipal Value Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund invests in undervalued municipal securities and other related investments the income from which is exempt from regular federal income taxes. It seeks to invest in investment grade securities with an average maturity of around 23.00 years. The fund employs fundamental analysis with a focus on bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Dividend Advantage Municipal Fund 3 was formed on July 27, 2009 and is domiciled in the United States.

Volume

Today’s last reported volume for Nuveen Enhanced Municipal Value Fund is 52892, 20.74% above its average volume of 43807.

Nuveen Enhanced Municipal Value Fund’s last close was $16.27, 7.82% below its 52-week high of $17.65.

Nuveen Enhanced Municipal Value Fund’s Stock Yearly Top and Bottom Value

Nuveen Enhanced Municipal Value Fund’s stock is valued at $17.42 at 05:15 EST, under its 52-week high of $17.65 and way higher than its 52-week low of $14.15.

Nuveen Enhanced Municipal Value Fund’s Moving Average

Nuveen Enhanced Municipal Value Fund’s value is above its 50-day moving average of $16.37 and higher than its 200-day moving average of $16.25.

More news about Nuveen Enhanced Municipal Value Fund.

3. Northrim BanCorp (NRIM) – Dividend Yield: 3.48%

Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement accounts, money market deposit accounts, and certificates of deposit. It also provides family residential mortgages; commercial loans, such as secured and unsecured loans for working capital and expansion; commercial real estate loans; construction loans for commercial real estate projects, and land development and residential subdivision construction loans; and loans for automobiles, recreational vehicles, boats, and other consumer purchases, as well as home equity and commercial credit lines, and factoring services. In addition, the company offers other services that include consumer online banking, mobile app and mobile deposit, mobile Web and text banking, business online banking, personal finance, online documents, consumer and business debit cards, home equity advantage access cards, and telebanking and automated teller services. Further, it provides personalized checks, overdraft protection from savings accounts, commercial drive-up banking, automatic transfers and payments, people pay, external and wire transfers, bill pay, direct payroll deposits, electronic tax payments, automated clearing house origination and receipt, remote deposit capture, and account reconciliation and positive pay services, as well as merchant and cash management programs, annuity products, and long term investment portfolios. As of December 31, 2020, the company operated 16 branches in Anchorage, the Matanuska-Susitna Valley, Juneau, Fairbanks, Ketchikan, Sitka, and Kenai Peninsula. Northrim BanCorp, Inc. was founded in 1990 and is headquartered in Anchorage, Alaska.

Volume

Today’s last reported volume for Northrim BanCorp is 14733, 7.24% below its average volume of 15883.

Northrim BanCorp’s last close was $43.55, 9.63% under its 52-week high of $48.19.

The company’s growth estimates for the present quarter and the next is a negative 27.6% and a negative 47.8%, respectively.

Northrim BanCorp’s Revenue

Year-on-year quarterly revenue growth grew by 83.8%, now sitting on 148.38M for the twelve trailing months.

Northrim BanCorp’s Stock Yearly Top and Bottom Value

Northrim BanCorp’s stock is valued at $42.75 at 05:15 EST, way below its 52-week high of $48.19 and way higher than its 52-week low of $20.90.

Northrim BanCorp’s Moving Average

Northrim BanCorp’s value is under its 50-day moving average of $43.96 and higher than its 200-day moving average of $40.27.

More news about Northrim BanCorp.

4. ENI S.p.A. (E) – Dividend Yield: 3.44%

Eni S.p.A. engages in the exploration, development, and production of crude oil and natural gas. It operates through Exploration & Production, Gas & Power, and Refining & Marketing and Chemical segments. The company is involved in the field development and production activities, as well as liquefied natural gas (LNG) operations in 41 countries, including Italy, Libya, Egypt, Norway, the United Kingdom, Angola, Congo, Nigeria, Mexico, the United States, Kazakhstan, Algeria, Australia, Iraq, Indonesia, Ghana, Mozambique, Bahrain, Oman, and United Arab Emirates. It also supplies, trades in, and markets gas and electricity; generates and sells electricity; transports international gas; supplies crude oil; and refines and markets petroleum products at retail and wholesale markets primarily in Italy and rest of Europe. In addition, the company engages in the petrochemicals business; commodity risk management and asset-backed trading activities; and production of various chemicals, including olefins and aromatics, basic and intermediate products, polystyrenes, elastomers, and polyethylene in Italy and Western Europe. Further, it is involved in commodity trading and derivatives. Eni S.p.A. was founded in 1953 and is headquartered in Rome, Italy.

Volume

Today’s last reported volume for ENI S.p.A. is 101388, 59.52% below its average volume of 250441.

ENI S.p.A.’s last close was $24.80, 5.27% under its 52-week high of $26.18.

ENI S.p.A.’s Revenue

Year-on-year quarterly revenue growth grew by 58.4%, now sitting on 6.94B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ENI S.p.A.’s stock is considered to be oversold (<=20).

ENI S.p.A.’s Stock Yearly Top and Bottom Value

ENI S.p.A.’s stock is valued at $24.67 at 05:15 EST, below its 52-week high of $26.18 and way higher than its 52-week low of $13.36.

ENI S.p.A.’s Moving Average

ENI S.p.A.’s worth is below its 50-day moving average of $25.10 and higher than its 200-day moving average of $23.50.

More news about ENI S.p.A..

5. Bristol (BMY) – Dividend Yield: 2.93%

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, and Ubiquigent Limited; clinical collaboration agreement with NeoImmuneTech, Inc.; and partnership with Astrazeneca Plc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

Volume

Today’s last reported volume for Bristol is 5601130, 45.38% below its average volume of 10255100.

Bristol’s last close was $66.56, 2.06% under its 52-week high of $67.96.

Bristol’s Sales

Bristol’s sales growth is 12% for the current quarter and 12.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 17.2% and 20.2%, respectively.

Bristol’s Revenue

Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 42.81B for the twelve trailing months.

Bristol’s Stock Yearly Top and Bottom Value

Bristol’s stock is valued at $66.95 at 05:15 EST, below its 52-week high of $67.96 and way above its 52-week low of $56.75.

Bristol’s Moving Average

Bristol’s value is higher than its 50-day moving average of $66.05 and higher than its 200-day moving average of $63.57.

More news about Bristol.

6. Camden National Corporation (CAC) – Dividend Yield: 2.93%

Camden National Corporation operates as the holding company for Camden National Bank that provides commercial and consumer banking products and services to consumer, institutional, municipal, non-profit, and commercial customers. It offers various deposit products, including demand, checking, saving, and money market accounts; and time deposits, as well as certificates of deposit. The company also originates single family and multi-family residential loans, commercial real estate loans, business loans, municipal loans, and various consumer loans, as well as loans for the construction of residential homes, multi-family properties, and commercial real estate properties; and commercial lending to the small business medical field, including dentists, optometrists, and veterinarians. In addition, the company provides brokerage and insurance services through its financial offerings consisting of college, retirement, estate planning, mutual funds, strategic asset management accounts, and variable and fixed annuities. Further, it offers a range of investment management, financial planning, fiduciary, asset management, and wealth management services, as well as serves as trustee. As of December 31, 2019, the Bank had 60 branches in 16 counties; 71 ATMs; commercial loan production offices in Manchester and Portsmouth, New Hampshire; and a mortgage loan production office in Braintree, Massachusetts. The company was founded in 1875 and is headquartered in Camden, Maine.

Volume

Today’s last reported volume for Camden National Corporation is 2036, 95.3% below its average volume of 43278.

Camden National Corporation’s last close was $47.62, 4.11% under its 52-week high of $49.66.

Camden National Corporation’s Sales

Camden National Corporation’s sales growth is a negative 0.7% for the ongoing quarter and a decline by 5.1% for the next. The company’s growth estimates for the ongoing quarter is 53.4% and a drop 9% for the next.

Camden National Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 182.48M for the twelve trailing months.

Camden National Corporation’s Stock Yearly Top and Bottom Value

Camden National Corporation’s stock is valued at $47.76 at 05:15 EST, below its 52-week high of $49.66 and way higher than its 52-week low of $28.32.

Camden National Corporation’s Moving Average

Camden National Corporation’s worth is above its 50-day moving average of $47.53 and higher than its 200-day moving average of $43.87.

More news about Camden National Corporation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here